These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26108057)

  • 1. Neuropathic Pain Following Poly-L-Lactic Acid (Sculptra) Injection.
    Vrcek I; El-Sawy T; Chou E; Allen T; Nakra T
    Ophthalmic Plast Reconstr Surg; 2017; 33(3S Suppl 1):S11-S12. PubMed ID: 26108057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angioedema after treatment with injectable poly-L-lactic acid (sculptra).
    Guardiani E; Davison SP
    Plast Reconstr Surg; 2012 Jan; 129(1):187e-189e. PubMed ID: 22186556
    [No Abstract]   [Full Text] [Related]  

  • 3. Midface injectable fillers: have they replaced midface surgery?
    Pontius AT; Chaiet SR; Williams EF
    Facial Plast Surg Clin North Am; 2013 May; 21(2):229-39. PubMed ID: 23731584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Injectable poly-L-lactic acid (Sculptra): technical considerations in soft-tissue contouring.
    Lam SM; Azizzadeh B; Graivier M
    Plast Reconstr Surg; 2006 Sep; 118(3 Suppl):55S-63S. PubMed ID: 16936545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sculptra: the new three-dimensional filler.
    Sherman RN
    Clin Plast Surg; 2006 Oct; 33(4):539-50. PubMed ID: 17085222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late-onset, recurrent facial nodules associated with injection of poly-L-lactic acid.
    Hamilton DG; Gauthier N; Robertson BF
    Dermatol Surg; 2008 Jan; 34(1):123-6; discussion 126. PubMed ID: 18053031
    [No Abstract]   [Full Text] [Related]  

  • 7. Late-onset subcutaneous nodules after poly-L-lactic acid injection.
    Reszko AE; Sadick NS; Magro CM; Farber J
    Dermatol Surg; 2009 Feb; 35 Suppl 1():380-4. PubMed ID: 19207329
    [No Abstract]   [Full Text] [Related]  

  • 8. Sculptra: a stimulatory filler.
    Lacombe V
    Facial Plast Surg; 2009 May; 25(2):95-9. PubMed ID: 19415576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Facial rejuvenation using L-polylactic acid: about 298 successive cases].
    Olivier Masveyraud F
    Ann Chir Plast Esthet; 2011 Apr; 56(2):120-7. PubMed ID: 20965636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommendations on the Use of Injectable Poly-L-Lactic Acid for Skin Laxity in Off-Face Areas.
    Haddad A; Menezes A; Guarnieri C; Coimbra D; Ribeiro E; Sarubi J; Avelar LE; Del Nero MP; da Cunha MG; Mazzuco R; Kamamoto C; Cazerta C
    J Drugs Dermatol; 2019 Sep; 18(9):929-935. PubMed ID: 31524350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgery for foreign body reactions due to injectable fillers.
    Wolfram D; Tzankov A; Piza-Katzer H
    Dermatology; 2006; 213(4):300-4. PubMed ID: 17135735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimizing adverse events associated with poly-L-lactic acid injection.
    Narins RS
    Dermatol Surg; 2008 Jun; 34 Suppl 1():S100-4. PubMed ID: 18547172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe visual loss and orbital infarction following periorbital aesthetic poly-(L)-lactic acid (PLLA) injection.
    Roberts SA; Arthurs BP
    Ophthalmic Plast Reconstr Surg; 2012; 28(3):e68-70. PubMed ID: 21862947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chart Review Presenting Safety of Injectable PLLA Used With Alternative Reconstitution Volume for Facial Treatments.
    Palm M; Mayoral F; Rajani A; Goldman MP; Fabi S; Espinoza L; Andriopoulos B; Harper J
    J Drugs Dermatol; 2021 Jan; 20(1):118-22. PubMed ID: 33400413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of visible granulomas following periorbital injection of poly-L-lactic Acid.
    Stewart DB; Morganroth GS; Mooney MA; Cohen J; Levin PS; Gladstone HB
    Ophthalmic Plast Reconstr Surg; 2007; 23(4):298-301. PubMed ID: 17667102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facial fillers: discussion and debate.
    Dayan SH; Ellis DA; Moran ML
    Facial Plast Surg Clin North Am; 2012 Aug; 20(3):245-64. PubMed ID: 22910020
    [No Abstract]   [Full Text] [Related]  

  • 17. Immediate Use After Reconstitution of a Biostimulatory Poly-L-Lactic Acid Injectable Implant.
    Baumann K; Alm J; Norberg M; Ejehorn M
    J Drugs Dermatol; 2020 Dec; 19(12):1199-1203. PubMed ID: 33346524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. European expert recommendations on the use of injectable poly-L-lactic acid for facial rejuvenation.
    Alessio R; Rzany B; Eve L; Grangier Y; Herranz P; Olivier-Masveyraud F; Vleggaar D
    J Drugs Dermatol; 2014 Sep; 13(9):1057-66. PubMed ID: 25226006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of sculptra mark in esthetic rejuvenation.
    Beer KR; Rendon MI
    Semin Cutan Med Surg; 2006 Sep; 25(3):127-31. PubMed ID: 17055391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contemporary review of injectable facial fillers.
    Kontis TC
    JAMA Facial Plast Surg; 2013 Jan; 15(1):58-64. PubMed ID: 23183718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.